Vaccination
Reinfection in COVID-19 – Part three
What are the implications of reinfection for vaccines, antibody passports and herd immunity asks University of Melbourne's Prof Peter Doherty?
Reinfection in COVID-19- Part two
What do cases of reinfection tell us about protective immunity against SARS-CoV-2 asks the University of Melbourne’s Prof Peter Doherty?
How can we make sure people trust a COVID-19 vaccine once we get one?
Vaccination is an insurance policy but University of Melbourne experts say if we want good COVID-19 vaccine uptake, we need to restore public trust and clarity.
Supply chain challenges ahead for the COVID-19 vaccine
Government and private sector collaboration will be key to sharing risks and opportunities for COVID-19 vaccine supply chain says University of Melbourne expert
Reinfection in COVID-19
SARS-CoV-2 mutational ‘bar codes’ can be used to test whether someone has been reinfected by COVID-19 virus says University of Melbourne expert Peter Doherty
Why we should grant patents on COVID-19 vaccines
COVID-19 vaccines must be available to all who need it. Patents can be part of the solution and not part of the problem says a University of Melbourne expert.
Gaining clarity on the ethical issues of a possible COVID-19 vaccine
Given the importance of a COVID-19 vaccine, we need to unpack religious and ethical concerns on using human cell lines say University of Melbourne experts.
Your protective Igs: The major focus of COVID-19 vaccines
As a scientists around the world continue to work on a COVID-19 vaccine – a University of Melbourne expert explains how and why they work at a cellular level.
The science behind the search for a COVID-19 vaccine
In a special report, University of Melbourne researchers take us behind the science of creating, testing and distributing a vaccine to end the COVID-19 pandemic
Lessons for a future pandemic
Professor Peter Doherty from the University of Melbourne discusses the latest COVID-19 drug and vaccine research, and how best to prepare for future pandemic